StonvexLoading…
StonvexStonvexStonvexCore line items from LYG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | £19.42B | £18.00B | £18.63B | £-5.35B |
Operating Income | £6.66B | £5.97B | £7.50B | £4.78B |
Net Income | £4.76B | £4.48B | £5.52B | £3.92B |
EPS (Diluted) | £0.07 | £0.06 | £0.07 | £0.05 |
Total Assets | £944.07B | £906.70B | £881.45B | £873.39B |
Total Liabilities | £896.21B | £860.81B | £834.09B | £829.48B |
Cash & Equivalents | £60.59B | £70.82B | £88.84B | £95.83B |
Free Cash Flow OCF − CapEx | £630.00M | £-8.76B | £2.85B | £19.58B |
Shares Outstanding | 59.18B | 60.91B | Not available | Not available |